|1.||Kaur, Gurcharan: 10 articles (01/2014 - 11/2002)|
|2.||Abe, K: 7 articles (01/2003 - 03/2001)|
|3.||Iwai, M: 6 articles (01/2003 - 03/2001)|
|4.||Sato, K: 6 articles (01/2003 - 03/2001)|
|5.||Rougon, G: 4 articles (06/2003 - 01/2000)|
|6.||Hayashi, T: 4 articles (12/2001 - 03/2001)|
|7.||Kim, Dong-Wook: 3 articles (05/2015 - 01/2012)|
|8.||Lee, Dongjin R: 3 articles (05/2015 - 01/2012)|
|9.||Kim, Dae-Sung: 3 articles (05/2015 - 01/2012)|
|10.||Kim, Han-Soo: 3 articles (05/2015 - 01/2012)|
01/01/1998 - "We conclude that PSA-NCAM expression is high in tumor specimens and serum of patients with advanced stages of RMS and decreases during successful therapy. "
01/01/2000 - "In the present study, we have searched for PSA-NCAM expression in four lineages of rat pituitary transplantable tumors (SMtTW). "
08/01/2014 - "Here, we summarize the functional role of PSA, PSA-NCAM and related cell signaling pathways in tumor development, progression and prognostic. "
08/01/2014 - "It was indicated that PSA and PSA-NCAM were tightly associated with cell adhesion, migration and invasion, and mediated tumor development and progression through certain cell signaling pathways. "
08/01/2014 - "It has been demonstrated that PSA and PSA-NCAM were re-expressed in some malignant tumors. "
01/01/2012 - "This study was designed to assess the effects of kindling either with or without maternal seizures on hippocampal PSA-NCAM expression in rat offspring. "
01/01/2011 - "Our study showed that maternal seizures reduced the number of neurons and also PSA-NCAM positive cells per unit area in the offspring hippocampus that it may cause impairment in hippocampal functions."
01/01/2011 - "The present study was designed to investigate the effect of maternal seizures on the number of PSA-NCAM positive cells in pup's hippocampus. "
01/01/2003 - "Immunoreactive PSA-NCAM expression was examined in rats with repeated exposure to amygdaloid kindled generalized seizures (GS). "
01/01/2003 - "Although PSA-NCAM positive dendrite in dentate gyrus was minimally found in the control brain, it extended slightly in animals with partial seizure, and greatly toward the molecular layer with generalized seizure. "
|3.||AIDS-Related Complex (ARC)
09/01/2010 - "The beta-END peri-neuronal space was affected negatively by the transition to SD: the percentage of PSA-NCAM on beta-END neurons decreased between D45 and D112 in the posterior two thirds of the arcuate nucleus (ARC). "
08/01/2005 - "PSA-NCAM expression was also seen on glial cells in the ME-ARC region. "
08/01/2005 - "The close association between PSA-NCAM on GnRH and glial cells in the ME-ARC region of the hypothalamus in the rat showed dynamic structural changes in GnRH neuron terminals during the estrous cycle. "
08/01/2005 - "Using immunohistofluorescent dual labeling, we determined that axon terminals of GnRH in the median arcuate nucleus (ME-ARC) region of the hypothalamus in the proestrous phase of the estrous cycle were intimately associated with PSA-NCAM. "
12/01/2007 - "GnRH and PSA-NCAM staining was much higher in mPOA and ME-ARC region from vehicle treated control proestrous rats, whereas VPA treatment significantly enhanced GABA expression, and reduced both GnRH and PSA-NCAM expression. "
|4.||Schizophrenia (Dementia Praecox)
11/14/2012 - "Different studies have found that PSA-NCAM expression in the hippocampus and the amygdala is altered in schizophrenia, major depression and animal models of these disorders, in parallel to changes in the expression of molecules related to inhibitory neurotransmission and synaptic plasticity. "
01/01/2014 - "In addition, altered PSA-NCAM expression in brains of patients with schizophrenia or bipolar disorder indicates a functional dysregulation of glycosylation in mental illness. "
11/14/2012 - "These results indicate that the expression of synaptic proteins is altered in the PFC of patients suffering from these disorders and that, particularly in schizophrenia, abnormal PSA-NCAM and GAD67 expression may underlie the alterations observed in inhibitory neurotransmission."
02/01/2012 - "The polysialylated neural cell adhesion molecule (PSA-NCAM), a molecule related to neuronal structural plasticity, which expression is altered in schizophrenia, major depression and in animal models of these disorders, may participate in these changes. "
08/04/2009 - "Interestingly, both PSA-NCAM and NCAM-EC have been implicated in the pathophysiology of schizophrenia. "
10/01/1998 - "The aim of the present study was to evaluate PSA-NCAM as a marker in childhood neuroblastoma. "
10/01/1998 - "We conclude that PSA-NCAM, both immunohistochemically and in the serum, is a promising candidate for another useful diagnostic and prognostic tumor marker in childhood neuroblastoma."
10/01/1998 - "PSA-NCAM expression was highest in patients with undifferentiated neuroblastoma and advanced stages of disease, whereas children with differentiated tumor types and low clinical stages had distinctly reduced or no reactivity in immunohistochemistry and, simultaneously, normal serum levels. "
06/13/2005 - "Neuroprotection mediated by subtoxic dose of NMDA in SH-SY5Y neuroblastoma cultures: activity-dependent regulation of PSA-NCAM expression."
10/01/1998 - "Neuroblastoma cells express the polysialylated form of the neural cell adhesion molecule (PSA-NCAM), which normally becomes restricted to a few neural regions after embryogenesis. "
|1.||Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)
|3.||Glial Fibrillary Acidic Protein
|5.||Gonadotropin-Releasing Hormone (GnRH)
|6.||Messenger RNA (mRNA)
|7.||Kainic Acid (Kainate)
|8.||Butyric Acid (Butanoic Acid)
|9.||Transcription Factor AP-1 (Transcription Factor AP 1)
|10.||NF-kappa B (NF-kB)
|3.||Transplantation (Transplant Recipients)
|4.||Tissue Therapy (Cell Therapy)